Mobile

Study at several locations, randomized, double-blind with crenolanib in comparison with placebo in patients with advanced or metastatic gastrointestinal stromal tumors with a specific mutation (D842V)...

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000287-34

Study at several locations, randomized, double-blind with crenolanib in comparison with placebo in patients with advanced or metastatic gastrointestinal stromal tumors with a specific mutation (D842V) in the PDGFRA gene

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the treatment effect of crenolanib with that of placebo on prolonging progression-free survival (PFS) in subjects with advanced or metastatic GIST with a PDGFRA D842V mutation.

Critère d'inclusion

  • Advanced or metastatic gastrointestinal stromal tumor (GIST)

Liens